AnaptysBio Inc (ANAB)
26.02
-0.32
(-1.21%)
USD |
NASDAQ |
May 03, 15:15
AnaptysBio 1 Year Total Returns (Daily): 25.61% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 25.61% |
| May 01, 2024 | 22.91% |
| April 30, 2024 | 16.91% |
| April 29, 2024 | 2.31% |
| April 26, 2024 | 0.14% |
| April 25, 2024 | -12.23% |
| April 24, 2024 | -11.03% |
| April 23, 2024 | -15.06% |
| April 22, 2024 | -12.93% |
| April 19, 2024 | -13.16% |
| April 18, 2024 | -10.84% |
| April 17, 2024 | -4.87% |
| April 16, 2024 | -0.88% |
| April 15, 2024 | -1.21% |
| April 12, 2024 | 7.48% |
| April 11, 2024 | 16.54% |
| April 10, 2024 | 3.21% |
| April 09, 2024 | 0.56% |
| April 08, 2024 | -3.46% |
| April 05, 2024 | -1.08% |
| April 04, 2024 | -1.84% |
| April 03, 2024 | -6.20% |
| April 02, 2024 | -4.23% |
| April 01, 2024 | -2.02% |
| March 28, 2024 | 4.26% |
| Date | Value |
|---|---|
| March 27, 2024 | -2.37% |
| March 26, 2024 | 0.93% |
| March 25, 2024 | -1.40% |
| March 22, 2024 | 1.93% |
| March 21, 2024 | 12.36% |
| March 20, 2024 | 10.73% |
| March 19, 2024 | 6.74% |
| March 18, 2024 | 6.28% |
| March 15, 2024 | 2.09% |
| March 14, 2024 | 3.10% |
| March 13, 2024 | 9.39% |
| March 12, 2024 | 16.50% |
| March 11, 2024 | 4.38% |
| March 08, 2024 | 5.35% |
| March 07, 2024 | 4.14% |
| March 06, 2024 | 7.87% |
| March 05, 2024 | 6.29% |
| March 04, 2024 | 9.74% |
| March 01, 2024 | 1.23% |
| February 29, 2024 | 2.53% |
| February 28, 2024 | 3.65% |
| February 27, 2024 | 7.65% |
| February 26, 2024 | 6.09% |
| February 23, 2024 | -0.04% |
| February 22, 2024 | -2.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.44%
Minimum
Nov 08 2019
192.1%
Maximum
Nov 10 2020
-10.55%
Average
-12.14%
Median
May 03 2023
1 Year Total Returns (Daily) Benchmarks
| XOMA Corp | 41.09% |
| Fate Therapeutics Inc | -30.91% |
| Ocular Therapeutix Inc | -1.76% |
| Apellis Pharmaceuticals Inc | -42.88% |
| Stoke Therapeutics Inc | 18.80% |